☆ 4.7 Meeting Abstract

Phase 2 Multicenter Trial Evaluating the Role of Induction TPF Followed by Weekly Docetaxel and Cetuximab in Combination With IMRT for Locally Recurrent Nasopharyngeal Carcinoma

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)

Journal

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Volume 99, Issue 2, Pages E351-E352

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.ijrobp.2017.06.1441

Keywords

-

Categories

Oncology Radiology, Nuclear Medicine & Medical Imaging

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Oncology

Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma

Shigemasa Takamizawa, Yoshitaka Honma, Naoya Murakami, Taisuke Mori, Hiroki Oka, Shun Yamamoto, Tairo Kashihara, Kimiteru Ito, Yuko Kubo, Atsuo Ikeda, Fumihiko Matsumoto, Go Omura, Kenya Kobayashi, Jun Itami, Ken Kato, Seiichi Yoshimoto

Summary: This study aimed to evaluate the short-term outcomes of locally advanced nasopharyngeal carcinoma patients treated with induction chemotherapy (IC) using TPF followed by chemoradiotherapy (CRT) with cisplatin. The results showed promising short-term effectiveness of IC-TPF followed by CRT, but also highlighted the high rates of hematological toxicity. Long-term follow-up is needed to further assess the clinical outcomes and late-phase toxicity of this therapeutic approach.

INVESTIGATIONAL NEW DRUGS (2021)

Add to Collection

Article Multidisciplinary Sciences

In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation

Michelle Jun, Harlan Pinto, Quynh-Thu Le, Andrew Quon, Wendy Hara, Jessie Coty, Alex McMillan, Rong Lu, Elzbieta Winters, Ruth Lira, A. Dimitrios Colevas

Summary: This study aimed to evaluate the efficacy and feasibility of full dose docetaxel, platinum, and 5-fluorouracil (TPF) in locally advanced or oligometastatic NPC patients. The results showed that the use of standard dose TPF combined with chemoradiation is both feasible and effective in this patient population.

PLOS ONE (2023)

Add to Collection

Article Oncology

Multicenter Retrospective Study of Weekly Cetuximab Plus Paclitaxel for Recurrent or Metastatic Oral Squamous Cell Carcinoma

Tomofumi Naruse, Souichi Yanamoto, Mitsunobu Otsuru, Nobuhiro Yamakawa, Tadaaki Kirita, Yukari Shintani, Tatsushi Matsumura, Masaya Okura, Masashi Sasaki, Yoshihide Ota, Shin-ichi Yamada, Hiroshi Kurita, Masahiro Umeda

Summary: The study suggests that the weekly cetuximab plus paclitaxel regimen may be a treatment option for patients with recurrent or metastatic oral squamous cell carcinoma that is refractory to platinum-based chemotherapy or progressive disease after chemotherapy. Adverse events were tolerable and manageable, with overall efficacy being relatively promising.

ANTICANCER RESEARCH (2021)

Add to Collection

Review Medicine, General & Internal

Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma

Ruijuan Chen, Yongkai Lu, Yuemei Zhang, Ruixin He, Fengwen Tang, Wei Yuan, Yi Li, Xiaowei Zhang

Summary: The TPF+CCRT regimen is superior to CCRT alone for the treatment of LA-NPC, showing improved overall survival and reduced risks of progression and distant metastasis, but also increasing the incidences of severe acute hematological toxicity and some non-hematological toxicities.

MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study

Takahiro Wakasaki, Tomomi Manako, Ryuji Yasumatsu, Hirotaka Hara, Satoshi Toh, Muneyuki Masuda, Moriyasu Yamauchi, Yuichiro Kuratomi, Emi Nishimura, Toranoshin Takeuchi, Mioko Matsuo, Rina Jiromaru, Kazuki Hashimoto, Noritaka Komune, Takashi Nakagawa

Summary: The study showed that patients receiving Cmab had significantly better overall survival and progression-free survival compared to those using PTX. However, the incidence of drug-induced interstitial pneumonia in patients receiving SCT treatment was 21.2%.

PLOS ONE (2022)

Add to Collection

Article Oncology

A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma

Mang Zhang, Yu Chen, Weili Wu, Feng Jin, Yuanyuan Li, Jinhua Long, Xiuling Luo, Xiuyun Gong, Xiaoxiao Chen, Lina Liu, Hong Tang, Ziqi Wang

Summary: This study compared the toxicity and clinical efficacy of TL regimen and TPF regimen in the treatment of locally advanced head and neck squamous cell carcinoma. The results showed that TL regimen had advantages in reducing toxic side effects and offered better survival time for patients who underwent surgery and had N1 or N2 stage.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Add to Collection

Article Oncology

Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma

Chwee Ming Lim, Anthony Liou, Michelle Poon, Liang Piu Koh, Lip Kun Tan, Kwok Seng Loh, Bengt Fredrik Petersson, Eric Ting, Dario Campana, Boon Cher Goh, Noriko Shimasaki

Summary: The study demonstrated that combining cetuximab with autologous expanded NK cells in patients with recurrent and/or metastatic NPC is safe and showed promising clinical responses, with some patients achieving durable stable disease.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Add to Collection

Article Otorhinolaryngology

Combining Transoral Nasopharyngeal Brush and Plasma Epstein-Barr Virus DNA in Detecting Locally Recurrent Nasopharyngeal Carcinoma

Ronald Lai, David Chun Man Yeung, Zenon Wing Chi Yeung, Thomas Sin Chun Hui, Wai Kei Jacky Lam, Kwan Chee Allen Chan, Cherrie Wing Kei Ng, Zion Wing Hei To, Ryan Hung Wai Cho, Catherine Po Ling Chan, Calvin Chee Fung Lai, Natalie Moon Wah Leung, Eddy Wai Yeung Wong, Joseph Chun Kit Chung, Raymond King Yin Tsang, Kenneth Wing Sum Li, James Chung Hang Chow, Ken Ka Man Cheung, Jason Y. K. Chan

Summary: This study evaluated the sensitivities and specificities of Epstein-Barr virus (EBV) DNA in detecting locally recurrent or persistent nasopharyngeal carcinoma (NPC) through nasopharyngeal (NP) brush biopsy and plasma, and investigated whether a combination of both tests would yield better results. The combined modalities had a sensitivity of 84.62%, specificity of 85.19%, positive predictive value of 73.33%, and negative predictive value of 92.0%. In conclusion, the combination of NP brush biopsy and plasma EBV DNA could be an additional surveillance method for detecting local recurrence of NPC.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2023)

Add to Collection

Article Oncology

Comparison of TPF and TP Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma Based on TNM Stage and Pretreatment Systemic Immune-Inflammation Index

Ying Xiong, Liangliang Shi, Lisheng Zhu, Gang Peng

Summary: The study showed that the TPF regimen had better 5-year DMFS for stage IVA and N2-3 patients, and in high-risk LA-NPC patients, TPF had higher 5-year OS and DMFS with more grade 3-4 toxicities.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Medicine, Research & Experimental

Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy

Xin Li, Lei Li, Ruimei Sun, Jingyan Gao, Zhengfei Li, Yongyuan Xue, Lixiu Zhu, Tianrui Xu, Chuanzheng Sun, Yan Xi, Wei Xiong

Summary: This meta-analysis compared the efficacy and toxicities of weekly and triweekly cisplatin regimens in patients with locally advanced nasopharyngeal cancer (LA-NPC). The results showed no significant difference in overall survival, distant metastasis-free survival, locoregional recurrence-free survival, and disease-free survival between the two regimens. However, the weekly cisplatin regimen was more likely to cause grade >= 3 hematological toxicity events. Subgroup analyses suggested similar survival rates for patients undergoing concurrent chemoradiotherapy (CCRT) and CCRT plus adjuvant chemotherapy (AC).

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2023)

Add to Collection

Article Otorhinolaryngology

Endoscopic surgery versus intensity-modulated radiotherapy in locally advanced recurrent nasopharyngeal carcinoma: a multicenter, case-matched comparison

Yibin Liu, Nan Huang, Junxiao Gao, Bin He, Hongming Huang, Liangcai Wan, Qinming Cai, Zhenchao Zhu, Suizi Zhou, Jing Wang, Xiaohui Wang, Qianhui Qiu, Fei Han

Summary: This study compared the clinical outcomes and complications of salvage endoscopic nasopharyngectomy (ENPG) with intensity-modulated radiotherapy (IMRT) in patients with locally advanced recurrent nasopharyngeal carcinoma (rNPC). The results showed that ENPG had comparable efficacy to IMRT but lower incidence of treatment-related complications.

JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2023)

Add to Collection

Article Oncology

Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma

Jing-Feng Zong, Qian-Dong Liang, Qiong-Jiao Lu, Yu-Hong Liu, Han-Chuan Xu, Bi-Juan Chen, Qiao-Juan Guo, Yun Xu, Cai-Rong Hu, Jian-Ji Pan, Shao-Jun Lin

Summary: This study compared the efficacy and toxicity of radiotherapy combined with nimotuzumab versus chemoradiotherapy in patients with locally recurrent nasopharyngeal carcinoma. The results showed no significant difference in survival rates between the two groups, but the CRT group had a higher incidence of severe late radiation injuries. Further studies are needed to confirm these findings.

BMC CANCER (2021)

Add to Collection

Review Oncology

International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma

Wai Tong Ng, Yoke Lim Soong, Yong Chan Ahn, Hussain AlHussain, Horace C. W. Choi, June Corry, Vincent Gregoire, Kevin J. Harrington, Chao Su Hu, Kenneth Jensen, Dora L. Kwong, Johannes A. Langendijk, Quynh Thu Le, Nancy Y. Lee, Jin Ching Lin, Tai Xiang Lu, William M. Mendenhall, Brian O'Sullivan, Enis Ozyar, Jian Ji Pan, Lester J. Peters, Sharon S. Poh, David I. Rosenthal, Giuseppe Sanguineti, Yungan Tao, Joseph T. Wee, Sue S. Yom, Melvin L. K. Chua, Anne W. M. Lee

Summary: The reirradiation for locally recurrent nasopharyngeal carcinoma (NPC) is challenging due to the delicate balance needed between achieving local salvage and minimizing treatment toxicities. High-level evidence is lacking, but pragmatic consensus guidelines based on expert opinions provide useful references for decision-making. Through iterative revisions, recommendations with high-to-moderate agreement were formulated regarding general treatment strategies and details of reirradiation.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Add to Collection

Article Otorhinolaryngology

Predicting the efficacy of chemoradiotherapy for locally advanced human papilloma virus-related oropharyngeal squamous cell carcinoma using one course of TPF chemotherapy

Takahito Kondo, Kiyoaki Tsukahara, Isaku Okamoto, Hiroki Sato, Takuro Okada, Ryo Maruyama, Kosuke Hihara, Tatsuya Ito, Atsuo Takeda, Naiue Kikawada, Yusuke Aihara, Yasuo Ogawa

Summary: One course of TPF chemotherapy can predict the efficacy of chemoradiotherapy in HPV-related oropharyngeal squamous cell carcinoma, with better outcomes for patients with complete or partial response to TPF. The efficacy of TPF is associated with the response rate of chemoradiotherapy, leading to high 2-year survival rates in the treatment group.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Add to Collection

Article Oncology

nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial

Peter Oppelt, Jessica Ley, Mackenzie Daly, Jason Rich, Randal Paniello, Ryan S. Jackson, Patrik Pipkorn, Jingxia Liu, Hiram Gay, Kevin Palka, Prakash Neupane, Steven Powell, William C. Spanos, Mark Gitau, Jose Zevallos, Wade Thorstad, Douglas Adkins

Summary: In locally advanced head and neck squamous-cell carcinoma (LA-HNSCC), a higher cCR rate was observed after induction chemotherapy with nab-paclitaxel and cisplatin, compared to nab-paclitaxel monotherapy. The trial results suggest that combination therapy may be more effective in achieving clinical complete response in LA-HNSCC patients.

MEDICAL ONCOLOGY (2021)

Add to Collection

Editorial Material Oncology

Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box?

Wai-Tong Ng, Melvin L. K. Chua, Anne W. M. Lee

JAMA ONCOLOGY (2022)

Add to Collection

Review Oncology

Management of Nasopharyngeal Carcinoma in Elderly Patients

Wing Lok Chan, James Chung Hang Chow, Zhi-yuan Xu, Jishi Li, Wing Tung Gobby Kwong, Wai Tong Ng, Anne W. M. Lee

Summary: Nasopharyngeal cancer is a difficult cancer to treat in the head and neck region, especially in elderly patients. The management of NPC in these patients requires a comprehensive evaluation to determine the most suitable treatment plan.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Wai-Tong Ng, Cheuk-Wai Choi, Barton But, Roger K. C. Ngan, Stewart Tung, Ashley C. Cheng, Dora L. W. Kwong, Tai-Xiang Lu, Anthony T. C. Chan, Harry Yiu, Sarah Lee, Frank Wong, Kam-Tong Yuen, Richard J. Chappell, Anne W. M. Lee

Summary: The combination of cisplatin-based induction or adjuvant chemotherapy with concurrent chemoradiotherapy has been found to improve overall survival in patients with locoregionally advanced nasopharyngeal carcinoma. The optimal platinum doses for the concurrent and induction/adjuvant phases were determined to be 160 mg/m(2) and 260 mg/m(2) respectively.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Editorial Material Oncology

The Janus Face in Defining the Optimal Radiation Dose for Nasopharyngeal Carcinoma

Sweet Ping Ng, June Corry, Wai-Tong Ng

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Add to Collection

Editorial Material Oncology

Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis?

Wai-Tong Ng, Melvin L. K. Chua, Anne W. M. Lee

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Editorial Material Oncology

Management of the neck in nasopharyngeal carcinoma-time for a radical change?

Melvin L. K. Chua, Joanne Y. H. Lua, Wai-Tong Ng, Anne W. M. Lee

CHINESE CLINICAL ONCOLOGY (2023)

Add to Collection

Review Medicine, Research & Experimental

Management of Older Patients with Head and Neck Cancer: A Comprehensive Review

Leandro L. Matos, Alvaro Sanabria, K. Thomas Robbins, Gyorgy B. Halmos, Primoz Strojan, Wai Tong Ng, Robert P. Takes, Peter Angelos, Cesare Piazza, Remco de Bree, Ohad Ronen, Orlando Guntinas-Lichius, Avraham Eisbruch, Mark Zafereo, Antti A. Makitie, Ashok R. Shaha, Andres Coca-Pelaz, Alessandra Rinaldo, Nabil F. Saba, Oded Cohen, Fernando Lopez, Juan P. Rodrigo, Carl E. Silver, Timo E. Strandberg, Luiz Paulo Kowalski, Alfio Ferlito

Summary: The projected increase in life expectancy is expected to lead to a rise in age-related diseases, including cancer. This report critically reviews the literature on managing older patients with head and neck cancer (HNC). Older adults, especially those who are frail or have comorbidities, are more prone to complications and toxicities from HNC treatment. Screening older patients for predispositions and managing comorbidities is essential. Age alone should not be a determining factor for less intensive treatment, and older patients should be treated according to the best standard of care to avoid increased treatment failure rates and mortality. A multidisciplinary tumor board should establish the treatment plan, involving shared decision-making with patients and family, and treatment modifications should be considered for patients with severe comorbidities, frailty, or who refuse recommendations.

ADVANCES IN THERAPY (2023)

Add to Collection

Article Medicine, General & Internal

Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Rui You, You -Ping Liu, Yu -Long Xie, Chao Lin, Chong -Yang Duan, Dong-Ping Chen, Yi Pan, Bin Qi, Xiong Zou, Ling Guo, Jing-Yu Cao, Yi-Nuan Zhang, Zhi-Qiang Wang, Yong -Long Liu, Yan-Feng Ouyang, Kai Wen, Qi Yang, Ruo-Qi Xie, Hui-Feng Li, Xiao-Tong Duan, Xi Ding, Lan Peng, Si -Yuan Chen, Jiong-Lin Liang, Zheng-Kai Feng, Tian-Liang Xia, Rui-Ling Xie, Rou Jiang, Chen-Mei Gu, Rong-Zeng Liu, Rui Sun, Xin Yang, Li-Zhi Liu, Li Ling, Qing Liu, Wai Tong Ng, Yi-Jun Hua, Pei-Yu Huang, Ming-Yuan Chen

Summary: This study compared the efficacy and safety of hyperfractionation with standard fractionation in intensity-modulated radiotherapy. The results showed that hyperfractionation significantly reduced the incidence of severe late complications and improved overall survival, suggesting that it could be used as the standard of care for patients with locally advanced recurrent nasopharyngeal carcinoma.

LANCET (2023)

Add to Collection

Article Oncology

Optimal time for early therapeutic response prediction in nasopharyngeal carcinoma with functional magnetic resonance imaging

Alan W. L. Mui, Anne W. M. Lee, Wai-Tong Ng, Victor H. F. Lee, Varut Vardhanabhuti, Shei-Yee Man, Daniel T. T. Chua, Xin-Yuan Guan

Summary: This study aimed to investigate the optimal time for early therapeutic response prediction with multi-parametric magnetic resonance imaging (MRI) in patients with nasopharyngeal carcinoma (NPC) receiving concurrent chemo-radiotherapy (CCRT). The results showed that DW-MRI on week-1 and DCE-MRI on week-2 can serve as the optimal time points for early therapeutic response prediction.

PHYSICS & IMAGING IN RADIATION ONCOLOGY (2023)

Add to Collection

Article Health Care Sciences & Services

The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours

Aya El Helali, Tai-Chung Lam, Elaine Yee-Ling Ko, David J. H. Shih, Chun Kau Chan, Charlene H. L. Wong, Jason W. H. Wong, Lydia W. T. Cheung, Johnny K. S. Lau, Anthony P. Y. Liu, Ann S. Y. Chan, Herbert H. Loong, Stephen Tak Sum Lam, Godfrey Chi-Fung Chan, Victor H. F. Lee, Kwok Keung Yuen, Wai-Tong Ng, Anne W. M. Lee, Edmond S. K. Ma

Summary: This study investigated the feasibility of the HKU-HKSH Multi-disciplinary Molecular Tumour Board (MTB) in determining genome-guided therapy for treatment-refractory solid cancers in Hong Kong. The results showed that MTB-guided treatment positively impacted patients' overall survival, illustrating the applicability of next-generation sequencing comprehensive gene profiling (CGP) in real-world clinical practice.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)

Add to Collection

Editorial Material Oncology

Small Changes, Big Impact: Excitement and Caution in Dose and Volume Reduction for Nasopharyngeal Carcinoma Radiation Therapy After Induction Chemotherapy

Ezra Hahn, Wai Tong Ng

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Add to Collection

Review Oncology

Predictive accuracy of machine learning for radiation-induced temporal lobe injury in nasopharyngeal carcinoma patients: a systematic review and meta-analysis

Yiling Li, Fengyuan Gong, Yangyang Guo, Wai Tong Ng, Michael Benedict A. Mejia, Wen-Long Nei, Cuicui Wang, Zhanguo Jin

Summary: Radiotherapy is a common treatment for nasopharyngeal carcinoma (NPC) but can cause radiation-induced temporal lobe injury (RTLI). Predicting RTLI at the early stage using machine learning (ML) models can help personalize radiation dose adjustment. However, the accuracy of these models remains unclear, warranting a meta-analysis for evaluation.

TRANSLATIONAL CANCER RESEARCH (2023)

Add to Collection

Review Oncology

Treatment strategy for de novo metastatic nasopharyngeal carcinoma: a literature review

Qin Liu, Jishi Li, Wai Tong Ng, Anne W. M. Lee

Summary: This review discusses the personalized and intensified treatment strategies for de novo metastatic NPC. Researchers have attempted to define M1 subcategorization to reflect the risk profile and tailor personalized treatment. The multimodality approach incorporating chemotherapy, immunotherapy, locoregional radiation, and ablative treatment to metastatic sites has been shown to improve overall control.

CHINESE CLINICAL ONCOLOGY (2023)

Add to Collection

Article Health Care Sciences & Services

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a II clinical trial

Chi Leung Chiang, Tai Chung Lam, James Chun Bong Li, Kenneth Sik Kwan Chan, Aya El Helali, Yolanda Yim Ping Lee, Laalaa Hiu Ting Law, Danyang Zheng, Anthony Wing Ip Lo, Ngar Woon Kam, Wing Sum Li, Alice Ka Wai Cheung, James Chung Hang Chow, Sunny Po Chung Chan, Jessica Wing Yu Lai, Sarah Wai Man Lee, Feng-Ming (Spring) Kong, Wai Tong Ng, Dora Lai Wan Kwong, Anne Wing Mui Lee

Summary: This study evaluated the safety and efficacy of bintrafusp alfa in platinum-refractory recurrent or metastatic nasopharyngeal cancer patients. The results showed that bintrafusp alfa demonstrated modest treatment activity, but the high rates of hyper-progressive disease and treatment discontinuation due to treatment-related adverse events are concerning.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)

Add to Collection

Article Oncology

Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis

Claire Petit, Anne Lee, Jun Ma, Benjamin Lacas, Wai Tong Ng, Anthony T. C. Chan, Ruey-Long Hong, Ming-Yuan Chen, Lei Chen, Wen-Fei Li, Pei-Yu Huang, Terence Tan, Roger K. C. Ngan, Guopei Zhu, Hai-Qiang Mai, Edwin P. Hui, George Fountzilas, Li Zhang, Alexandra Carmel, Dora L. W. Kwong, James Moon, Jean Bourhis, Anne Auperin, Jean-Pierre Pignon, Pierre Blanchard

Summary: This study updated the evaluation of chemotherapy for nasopharynx carcinoma through a network meta-analysis. The results showed that the addition of induction chemotherapy or adjuvant chemotherapy to chemoradiotherapy improved overall survival for patients with non-metastatic nasopharyngeal carcinoma compared to chemoradiotherapy alone.

LANCET ONCOLOGY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.